Suchergebnisse - "2212-4063" OR "1871-529X"

PubPharm (14)

1

Pre-Admission Beta-Blocker Therapy and Outcomes of Coronavirus Disease 2019 (COVID-19): A Systematic Review, Meta-Analysis, and Meta-Regression

enthalten in: Cardiovascular & hematological disorders, drug targets | 2023

von Hariyanto, T. | Hananto, J. | Intan, D. | +1

2

Pre-Admission Beta-Blocker Therapy and Outcomes of Coronavirus Disease 2019 (COVID-19) : A Systematic Review, Meta-Analysis, and Meta-Regression

enthalten in: Cardiovascular & hematological disorders drug targets | 2022

von Hariyanto, T. | Hananto, J. | Intan, D. | +1

3

Incidence and Management of Carfilzomib-induced Cardiovascular Toxicity; A Systematic Review and Meta-analysis

enthalten in: Cardiovascular & hematological disorders drug targets | 2021

von Latif, A. | Kapoor, V. | Lateef, N. | +9

4

Incidence and Management of Carfilzomib-induced Cardiovascular Toxicity; A Systematic Review and Meta-analysis

enthalten in: Cardiovascular & hematological disorders, drug targets | 2021

von Latif, A. | Kapoor, V. | Lateef, N. | +9

5

Is the Detection of Factor IX Inhibitors in Hemophilia B Orphan than Factor VIII Inhibitors in Hemophilia A? A Concise, Systematic Review

enthalten in: Cardiovascular & hematological disorders drug targets | 2020

von Mansouritorghabeh, H. | Mohades, S.

6

Bivalirudin Versus Heparin During Intervention in Acute Coronary Syndrome : A Systematic Review of Randomized Trials

enthalten in: Cardiovascular & hematological disorders drug targets | 2020

von Bhogal, S. | Mukherjee, D. | Bagai, J. | +6

7

Blood Biomarkers for the Differentiation of Cardiac Ischemic Stroke Subtypes: A Systematic Review

enthalten in: Cardiovascular & hematological disorders, drug targets | 2019

von Pathak, A. | Pandey, S. | Madhukar, P. | +4

8

Blood Biomarkers for the Differentiation of Cardiac Ischemic Stroke Subtypes : A Systematic Review

enthalten in: Cardiovascular & hematological disorders drug targets | 2019

von Pathak, A. | Pandey, S. | Madhukar, P. | +4

9

Is Anticoagulation with Novel Oral Anticoagulants an Effective Treatment for Tuberculosis Patients not Achieving a Therapeutic Range with Vitamin K Antagonists? A Systematic Review

enthalten in: Cardiovascular & hematological disorders drug targets | 2017

von Fiore, M. | Maraolo, A. | Chiodini, P. | +4

10

Nanomedicine in the Diagnosis and Treatment of Atherosclerosis-A Systematic Review

enthalten in: Cardiovascular & hematological disorders drug targets | 2017

von Vaidyanathan, K. | Gopalakrishnan, S.